ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
otherperspective
|
18K |
6.9M |
43 |
26/05/22 |
26/05/22 |
ASX - By Stock
|
18K
|
6.9M
|
43
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
otherperspective
|
18K |
6.9M |
52 |
24/05/22 |
24/05/22 |
ASX - By Stock
|
18K
|
6.9M
|
52
|
|
ASX - By Stock
|
MSB |
Re:
Crohn’s Disease
|
|
otherperspective
|
150 |
55K |
44 |
20/05/22 |
20/05/22 |
ASX - By Stock
|
150
|
55K
|
44
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Litigation Update
|
|
otherperspective
|
82 |
25K |
64 |
19/05/22 |
19/05/22 |
ASX - By Stock
|
82
|
25K
|
64
|
|
ASX - By Stock
|
MSB |
Re:
MSB $1 Party
|
|
otherperspective
|
1.1K |
356K |
55 |
12/05/22 |
12/05/22 |
ASX - By Stock
|
1.1K
|
356K
|
55
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
otherperspective
|
18K |
6.9M |
66 |
27/04/22 |
27/04/22 |
ASX - By Stock
|
18K
|
6.9M
|
66
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Director Appointment
|
|
otherperspective
|
213 |
59K |
112 |
24/03/22 |
24/03/22 |
ASX - By Stock
|
213
|
59K
|
112
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2022, The TurnAround
|
|
otherperspective
|
1.0K |
334K |
86 |
23/03/22 |
23/03/22 |
ASX - By Stock
|
1.0K
|
334K
|
86
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Trading Halt
|
|
otherperspective
|
106 |
35K |
31 |
22/03/22 |
22/03/22 |
ASX - By Stock
|
106
|
35K
|
31
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Trading Halt
|
|
otherperspective
|
106 |
35K |
17 |
21/03/22 |
21/03/22 |
ASX - By Stock
|
106
|
35K
|
17
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Trading Halt
|
|
otherperspective
|
106 |
35K |
34 |
18/03/22 |
18/03/22 |
ASX - By Stock
|
106
|
35K
|
34
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
otherperspective
|
18K |
6.9M |
78 |
07/03/22 |
07/03/22 |
ASX - By Stock
|
18K
|
6.9M
|
78
|
|
ASX - By Stock
|
MSB |
Re:
Silviu Itescu The Legend
|
|
otherperspective
|
880 |
217K |
113 |
15/02/22 |
15/02/22 |
ASX - By Stock
|
880
|
217K
|
113
|
|
ASX - By Stock
|
MSB |
Re:
Silviu Itescu The Legend
|
|
otherperspective
|
880 |
217K |
34 |
02/02/22 |
02/02/22 |
ASX - By Stock
|
880
|
217K
|
34
|
|
ASX - By Stock
|
MSB |
Re:
Silviu Itescu The Legend
|
|
otherperspective
|
880 |
217K |
45 |
02/02/22 |
02/02/22 |
ASX - By Stock
|
880
|
217K
|
45
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Appendix 4C Quarterly Activity Report
|
|
otherperspective
|
151 |
41K |
43 |
31/01/22 |
31/01/22 |
ASX - By Stock
|
151
|
41K
|
43
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB 2022 - The road to commercialisation
|
|
otherperspective
|
1.5K |
510K |
26 |
31/01/22 |
31/01/22 |
ASX - By Stock
|
1.5K
|
510K
|
26
|
|
ASX - By Stock
|
MSB |
Re:
Ann: MSB Presents at Edison Group Global Healthcare Conference
|
|
otherperspective
|
267 |
65K |
25 |
29/01/22 |
29/01/22 |
ASX - By Stock
|
267
|
65K
|
25
|
|
ASX - By Stock
|
MSB |
Re:
Ann: MSB Presents at Edison Group Global Healthcare Conference
|
|
otherperspective
|
267 |
65K |
34 |
29/01/22 |
29/01/22 |
ASX - By Stock
|
267
|
65K
|
34
|
|
ASX - By Stock
|
MSB |
Re:
Ann: MSB Presents at Edison Group Global Healthcare Conference
|
|
otherperspective
|
267 |
65K |
40 |
28/01/22 |
28/01/22 |
ASX - By Stock
|
267
|
65K
|
40
|
|
ASX - By Stock
|
MSB |
Re:
Ann: MSB Presents at Edison Group Global Healthcare Conference
|
|
otherperspective
|
267 |
65K |
30 |
28/01/22 |
28/01/22 |
ASX - By Stock
|
267
|
65K
|
30
|
|
ASX - By Stock
|
MSB |
Re:
Ann: MSB Presents at Edison Group Global Healthcare Conference
|
|
otherperspective
|
267 |
65K |
66 |
27/01/22 |
27/01/22 |
ASX - By Stock
|
267
|
65K
|
66
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
otherperspective
|
18K |
6.9M |
71 |
27/01/22 |
27/01/22 |
ASX - By Stock
|
18K
|
6.9M
|
71
|
|
ASX - By Stock
|
MSB |
Re:
Silviu Itescu The Legend
|
|
otherperspective
|
880 |
217K |
76 |
24/01/22 |
24/01/22 |
ASX - By Stock
|
880
|
217K
|
76
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
otherperspective
|
18K |
6.9M |
20 |
20/01/22 |
20/01/22 |
ASX - By Stock
|
18K
|
6.9M
|
20
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
otherperspective
|
18K |
6.9M |
39 |
20/01/22 |
20/01/22 |
ASX - By Stock
|
18K
|
6.9M
|
39
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
otherperspective
|
18K |
6.9M |
32 |
20/01/22 |
20/01/22 |
ASX - By Stock
|
18K
|
6.9M
|
32
|
|
ASX - By Stock
|
MSB |
Re:
Silviu Itescu The Legend
|
|
otherperspective
|
880 |
217K |
39 |
19/01/22 |
19/01/22 |
ASX - By Stock
|
880
|
217K
|
39
|
|
ASX - By Stock
|
MSB |
Re:
Ann: 36-Month Results of Phase 3 Trial in Chronic Low Back Pain
|
|
otherperspective
|
373 |
89K |
74 |
14/01/22 |
14/01/22 |
ASX - By Stock
|
373
|
89K
|
74
|
|
ASX - By Stock
|
MSB |
Re:
Ann: 36-Month Results of Phase 3 Trial in Chronic Low Back Pain
|
|
otherperspective
|
373 |
89K |
48 |
12/01/22 |
12/01/22 |
ASX - By Stock
|
373
|
89K
|
48
|
|
ASX - By Stock
|
MSB |
Re:
Ann: 36-Month Results of Phase 3 Trial in Chronic Low Back Pain
|
|
otherperspective
|
373 |
89K |
56 |
12/01/22 |
12/01/22 |
ASX - By Stock
|
373
|
89K
|
56
|
|
ASX - By Stock
|
MSB |
Re:
Silviu Itescu The Legend
|
|
otherperspective
|
880 |
217K |
27 |
07/01/22 |
07/01/22 |
ASX - By Stock
|
880
|
217K
|
27
|
|
ASX - By Stock
|
MSB |
Re:
Silviu Itescu The Legend
|
|
otherperspective
|
880 |
217K |
22 |
07/01/22 |
07/01/22 |
ASX - By Stock
|
880
|
217K
|
22
|
|
ASX - By Stock
|
MSB |
Re:
Silviu Itescu The Legend
|
|
otherperspective
|
880 |
217K |
48 |
07/01/22 |
07/01/22 |
ASX - By Stock
|
880
|
217K
|
48
|
|
ASX - By Stock
|
MSB |
Re:
Silviu Itescu The Legend
|
|
otherperspective
|
880 |
217K |
46 |
05/01/22 |
05/01/22 |
ASX - By Stock
|
880
|
217K
|
46
|
|
ASX - By Stock
|
MSB |
Silviu Itescu The Legend
|
|
otherperspective
|
880 |
217K |
165 |
05/01/22 |
05/01/22 |
ASX - By Stock
|
880
|
217K
|
165
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Update on FDA Meeting for Remestemcel-L in Paediatric GvHD
|
|
otherperspective
|
211 |
74K |
73 |
31/12/21 |
31/12/21 |
ASX - By Stock
|
211
|
74K
|
73
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
otherperspective
|
18K |
6.9M |
23 |
30/12/21 |
30/12/21 |
ASX - By Stock
|
18K
|
6.9M
|
23
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
otherperspective
|
18K |
6.9M |
53 |
30/12/21 |
30/12/21 |
ASX - By Stock
|
18K
|
6.9M
|
53
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
otherperspective
|
5.7K |
2.8M |
62 |
16/12/21 |
16/12/21 |
ASX - By Stock
|
5.7K
|
2.8M
|
62
|
|
ASX - By Stock
|
OCC |
Re:
Ann: OrthoATI Tendon Clinical Study Success
|
|
otherperspective
|
241 |
66K |
23 |
10/12/21 |
10/12/21 |
ASX - By Stock
|
241
|
66K
|
23
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
otherperspective
|
5.7K |
2.8M |
39 |
05/12/21 |
05/12/21 |
ASX - By Stock
|
5.7K
|
2.8M
|
39
|
|
ASX - By Stock
|
MSB |
Re:
Growing doubt on COVID-19 Application
|
|
otherperspective
|
4.7K |
1.1M |
72 |
03/12/21 |
03/12/21 |
ASX - By Stock
|
4.7K
|
1.1M
|
72
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: PromarkerD outperforms standard of care tests for DKD
|
|
otherperspective
|
14 |
6.3K |
10 |
25/11/21 |
25/11/21 |
ASX - By Stock
|
14
|
6.3K
|
10
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
otherperspective
|
18K |
6.9M |
58 |
18/11/21 |
18/11/21 |
ASX - By Stock
|
18K
|
6.9M
|
58
|
|
ASX - By Stock
|
MSB |
Re:
Ann: AHA Late-Breaker - Rexlemestrocel Improves Cardiac Outcomes
|
|
otherperspective
|
1.0K |
281K |
55 |
18/11/21 |
18/11/21 |
ASX - By Stock
|
1.0K
|
281K
|
55
|
|
ASX - By Stock
|
MSB |
Re:
Ann: AHA Late-Breaker - Rexlemestrocel Improves Cardiac Outcomes
|
|
otherperspective
|
1.0K |
281K |
49 |
16/11/21 |
16/11/21 |
ASX - By Stock
|
1.0K
|
281K
|
49
|
|
ASX - By Stock
|
MSB |
Re:
Ann: CHF Late Breaker Presentation at American Heart Association
|
|
otherperspective
|
350 |
127K |
110 |
13/11/21 |
13/11/21 |
ASX - By Stock
|
350
|
127K
|
110
|
|
ASX - By Stock
|
MSB |
Re:
15 Days until doubt is removed
|
|
otherperspective
|
953 |
293K |
126 |
11/11/21 |
11/11/21 |
ASX - By Stock
|
953
|
293K
|
126
|
|
ASX - By Stock
|
MSB |
Re:
Novartis countdown
|
|
otherperspective
|
373 |
113K |
122 |
03/11/21 |
03/11/21 |
ASX - By Stock
|
373
|
113K
|
122
|
|